Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus.

Uyeki TM, Erlandson KJ, Korch G, O'Hara M, Wathen M, Hu-Primmer J, Hojvat S, Stemmy EJ, Donabedian A.

Emerg Infect Dis. 2016 Jul;22(7). doi: 10.3201/eid2207.160022.

2.

Clarification regarding novel Clostridium botulinum toxin.

Korch G.

J Infect Dis. 2014 Nov 1;210(9):1517. doi: 10.1093/infdis/jiu268. No abstract available.

3.

Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1.

Lipsitch M, Finelli L, Heffernan RT, Leung GM, Redd SC; 2009 H1n1 Surveillance Group..

Biosecur Bioterror. 2011 Jun;9(2):89-115. doi: 10.1089/bsp.2011.0007.

4.

Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program.

Salmon DA, Akhtar A, Mergler MJ, Vannice KS, Izurieta H, Ball R, Lee GM, Vellozzi C, Garman P, Cunningham F, Gellin B, Koh H, Lurie N; H1N1 Working Group of Federal Immunization Safety Task Force..

Pediatrics. 2011 May;127 Suppl 1:S78-86. doi: 10.1542/peds.2010-1722L. Review.

PMID:
21502251
5.

A computer simulation of vaccine prioritization, allocation, and rationing during the 2009 H1N1 influenza pandemic.

Lee BY, Brown ST, Korch GW, Cooley PC, Zimmerman RK, Wheaton WD, Zimmer SM, Grefenstette JJ, Bailey RR, Assi TM, Burke DS.

Vaccine. 2010 Jul 12;28(31):4875-9. doi: 10.1016/j.vaccine.2010.05.002.

6.

Framework for leadership and training of Biosafety Level 4 laboratory workers.

Le Duc JW, Anderson K, Bloom ME, Estep JE, Feldmann H, Geisbert JB, Geisbert TW, Hensley L, Holbrook M, Jahrling PB, Ksiazek TG, Korch G, Patterson J, Skvorak JP, Weingartl H.

Emerg Infect Dis. 2008 Nov;14(11):1685-8. doi: 10.3201/eid1411.080741.

7.

Absence of mycoplasma contamination in the anthrax vaccine.

Hart MK, Del Giudice RA, Korch GW Jr.

Emerg Infect Dis. 2002 Jan;8(1):94-6. No abstract available.

8.

Short report: prevalence of hantavirus infection in rodents associated with two fatal human infections in California.

Turell MJ, Korch GW, Rossi CA, Sesline D, Enge BA, Dondero DV, Jay M, Ludwig GV, Li D, Schmaljohn CS, et al.

Am J Trop Med Hyg. 1995 Feb;52(2):180-2.

PMID:
7872450
9.

Isolation and initial characterization of a newfound hantavirus from California.

Schmaljohn AL, Li D, Negley DL, Bressler DS, Turell MJ, Korch GW, Ascher MS, Schmaljohn CS.

Virology. 1995 Feb 1;206(2):963-72.

10.

Lymphocytic choriomeningitis virus infection and house mouse (Mus musculus) distribution in urban Baltimore.

Childs JE, Glass GE, Korch GW, Ksiazek TG, Leduc JW.

Am J Trop Med Hyg. 1992 Jul;47(1):27-34.

PMID:
1636880
11.
12.

Land use associations and changes in population indices of urban raccoons during a rabies epizootic.

Anthony JA, Childs JE, Glass GE, Korch GW, Ross L, Grigor JK.

J Wildl Dis. 1990 Apr;26(2):170-9.

PMID:
2338721
13.
14.
15.

Association of intraspecific wounding with hantaviral infection in wild rats (Rattus norvegicus).

Glass GE, Childs JE, Korch GW, LeDuc JW.

Epidemiol Infect. 1988 Oct;101(2):459-72.

16.

Evidence of human infection with a rat-associated Hantavirus in Baltimore, Maryland.

Childs JE, Glass GE, Korch GW, Arthur RR, Shah KV, Glasser D, Rossi C, Leduc JW.

Am J Epidemiol. 1988 Apr;127(4):875-8.

PMID:
3128102
17.

Prospective seroepidemiology of hantaviruses and population dynamics of small mammal communities of Baltimore, Maryland.

Childs JE, Glass GE, Korch GW, LeDuc JW.

Am J Trop Med Hyg. 1987 Nov;37(3):648-62.

PMID:
2891308
18.
19.

Sodium content of potable water: dietary significance.

Korch GC.

J Am Diet Assoc. 1986 Jan;86(1):80-3.

PMID:
3941232
20.

Geographical distribution and age related prevalence of antibody to Hantaan-like virus in rat populations of Baltimore, Maryland, USA.

Childs JE, Korch GW, Smith GA, Terry AD, Leduc JW.

Am J Trop Med Hyg. 1985 Mar;34(2):385-7.

PMID:
3885776
Items per page

Supplemental Content

Loading ...
Support Center